• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫显性的H-2Kb限制性表位间的超显性及树突状细胞介导的抗原递呈导致的逆转

Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery.

作者信息

Sandberg J K, Grufman P, Wolpert E Z, Franksson L, Chambers B J, Kärre K

机构信息

Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.

出版信息

J Immunol. 1998 Apr 1;160(7):3163-9.

PMID:9531271
Abstract

To examine possible interference patterns between immunodominant CTL Ags, we analyzed the response to mixtures of five well-characterized H-2Kb-restricted epitopes, each of which had earlier been described as immunodominant within its antigenic system. Clear patterns of dominance were observed between peptides in the mixture, with the CTL response focusing on the Sendai virus nucleoprotein 324-332 and vesicular stomatitis virus nucleoprotein 52-59 epitopes. The dominance of these epitopes correlated with high CTL availability. Subdominance of the OVA(257-264) and the MCF1233 murine leukemia virus envelope 574-581 peptides could not be explained by inferior ability to bind and stabilize MHC class I molecules. Interestingly, immunodominance was broken if the peptide mixture was pulsed on bone marrow-derived dendritic cells, a mode of immunization allowing efficient recognition of a broader set of specificities. Our results show that immunodominance is neither an absolute feature of a given epitope nor does it apply only in relation to other epitopes within the same protein, micro-organism, or cell. Novel "superdominant" hierarchies emerge in the response against multiple "dominant" epitopes. A T cell competition model to explain the data in terms of a balance influenced by CTL frequencies and available APC capacity is discussed.

摘要

为了研究免疫显性CTL抗原之间可能存在的干扰模式,我们分析了对五个特征明确的H-2Kb限制性表位混合物的反应,每个表位在其抗原系统中先前都被描述为免疫显性。在混合物中的肽之间观察到了明显的优势模式,CTL反应集中在仙台病毒核蛋白324-332和水泡性口炎病毒核蛋白52-59表位上。这些表位的优势与高CTL可用性相关。OVA(257-264)和MCF1233鼠白血病病毒包膜574-581肽的次优势不能用结合和稳定MHC I类分子的能力较差来解释。有趣的是,如果将肽混合物加载到骨髓来源的树突状细胞上,免疫显性就会被打破,这种免疫方式能够有效识别更广泛的特异性。我们的结果表明,免疫显性既不是给定表位的绝对特征,也不仅仅适用于同一蛋白质、微生物或细胞内的其他表位。在针对多个“显性”表位的反应中出现了新的“超显性”层次结构。讨论了一个T细胞竞争模型,该模型根据CTL频率和可用APC能力影响的平衡来解释数据。

相似文献

1
Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery.免疫显性的H-2Kb限制性表位间的超显性及树突状细胞介导的抗原递呈导致的逆转
J Immunol. 1998 Apr 1;160(7):3163-9.
2
Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.对多瘤病毒诱导肿瘤的抗性与细胞毒性T淋巴细胞(CTL)对中间T蛋白中一个免疫显性的、受H-2Dk限制的表位的识别相关。
J Immunol. 1998 Feb 15;160(4):1724-34.
3
Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.针对次要组织相容性抗原的细胞毒性T淋巴细胞反应中的免疫显性:反应性T细胞之间的干扰,而非表位呈递的干扰。
J Immunol. 1998 Nov 1;161(9):4499-505.
4
The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.淋巴细胞性脉络丛脑膜炎病毒的信号序列包含一个免疫显性细胞毒性T细胞表位,该表位受H-2D(b)和H-2K(b)分子的限制。
Virology. 1997 Jul 21;234(1):62-73. doi: 10.1006/viro.1997.8627.
5
On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.关于细胞毒性T淋巴细胞对次要组织相容性抗原反应中免疫显性的机制
Eur J Immunol. 1997 Feb;27(2):421-30. doi: 10.1002/eji.1830270212.
6
MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL.MHC亲和力、肽释放、T细胞库和免疫显性均导致抗病毒CTL识别的MHC I类限制性肽数量稀少。
J Immunol. 1997 Feb 15;158(4):1507-15.
7
Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.一种具有增强的MHC I类结合和免疫原性特性的小鼠突变型Ras CD8+ CTL肽表位变体的开发。
J Immunol. 1998 Mar 1;160(5):2433-41.
8
Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.通过其MHC I类结合基序鉴定出的免疫显性水貂细胞灶诱导型鼠白血病病毒(MuLV)编码的CTL表位,解释了针对MCF的细胞毒性T淋巴细胞的MuLV类型特异性。
J Immunol. 1994 Jan 1;152(1):106-16.
9
Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.免疫显性多瘤病毒特异性CTL对两种中T蛋白表位的交叉识别
J Immunol. 1999 Apr 1;162(7):3933-41.
10
The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.BALB/c小鼠对HIV - gag的MHC I类限制性免疫反应选择了一个单一表位,该表位没有可预测的MHC结合基序,并且通过P3位的谷氨酰胺与口袋D之间的相互作用与Kd结合。
J Immunol. 1998 Sep 15;161(6):2985-93.

引用本文的文献

1
Individual Epitope-Specific CD8 T Cell Immune Responses Are Shaped Differently during Chronic Viral Infection.在慢性病毒感染期间,个体表位特异性CD8 T细胞免疫反应的形成方式有所不同。
Pathogens. 2023 May 14;12(5):716. doi: 10.3390/pathogens12050716.
2
Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge.用表达蓝舌病毒亚基VP7和VP2的重组腺病毒进行疫苗接种可提供针对异源病毒攻击的保护。
Front Vet Sci. 2021 Mar 10;8:645561. doi: 10.3389/fvets.2021.645561. eCollection 2021.
3
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.
新辅助 PD-1 免疫检查点阻断逆转肿瘤抗原特异性 T 细胞的功能优势。
Clin Cancer Res. 2020 Feb 1;26(3):679-689. doi: 10.1158/1078-0432.CCR-19-2209. Epub 2019 Oct 23.
4
How patients with an intact immune system develop head and neck cancer.免疫系统健全的患者如何患上头颈部癌症。
Oral Oncol. 2019 May;92:26-32. doi: 10.1016/j.oraloncology.2019.03.010. Epub 2019 Mar 18.
5
Whole Tumor Antigen Vaccines: Where Are We?全肿瘤抗原疫苗:我们目前的进展如何?
Vaccines (Basel). 2015 Apr 23;3(2):344-72. doi: 10.3390/vaccines3020344.
6
CD8 T cell epitope distribution in viruses reveals patterns of protein biosynthesis.CD8 T 细胞表位在病毒中的分布揭示了蛋白质生物合成的模式。
PLoS One. 2012;7(8):e43674. doi: 10.1371/journal.pone.0043674. Epub 2012 Aug 27.
7
CD8+ T-cell cross-competition is governed by peptide-MHC class I stability.CD8+ T 细胞交叉竞争受肽-MHC Ⅰ类稳定性的控制。
Eur J Immunol. 2012 Jan;42(1):256-63. doi: 10.1002/eji.201142010. Epub 2011 Nov 28.
8
No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.在 HIV-1 感染中,细胞毒性 T 淋巴细胞反应之间没有竞争的证据。
Proc Biol Sci. 2009 Dec 22;276(1677):4389-97. doi: 10.1098/rspb.2009.1232. Epub 2009 Sep 23.
9
Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.内质网氨肽酶1(ERAP1)在体内修剪主要组织相容性复合体I类呈递的肽,并在免疫显性中发挥重要作用。
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9202-7. doi: 10.1073/pnas.0603095103. Epub 2006 Jun 5.
10
Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector cells eradicate established tumors.功能性内源性细胞毒性T淋巴细胞针对进展期肿瘤共表达的多种抗原产生;肿瘤内注射白细胞介素-2治疗后,这些效应细胞可根除已形成的肿瘤。
Cancer Immunol Immunother. 2006 Aug;55(8):933-47. doi: 10.1007/s00262-005-0086-6. Epub 2005 Nov 11.